LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced LinearDNA as Substitute for Plasmid DNA in IVT mRNA Production at the 2nd Annual mRNA-Based Therapeutics Summit
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
